HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center

被引:6
|
作者
Bae, Sung Kwan [1 ]
Gushima, Toshifumi [1 ]
Saito, Noriyuki [2 ]
Yamanaka, Ikumi [2 ]
Matsuo, Yayoi [2 ]
Yoshida, Shuro [2 ]
Kawano, Ichiro [2 ]
Henzan, Hideho [2 ]
Shimoda, Shinji [3 ]
Eto, Tetsuya [2 ]
Takahashi, Kazuhiro [1 ]
机构
[1] Hamanomachi Hosp, Ctr Liver Dis, Chuo Ku, 3-3-1 Nagahama, Fukuoka, Fukuoka 8108539, Japan
[2] Hamanomachi Hosp, Dept Hematol, Fukuoka, Fukuoka, Japan
[3] Kyushu Univ, Med & Biosyst Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan
关键词
HEPATITIS-B INFECTION; VIRUS REACTIVATION; MULTIPLE-MYELOMA; BORTEZOMIB; THERAPY; PATIENT; RISK;
D O I
10.1038/s41409-018-0355-6
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:629 / 631
页数:3
相关论文
共 50 条
  • [1] HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center
    Sung Kwan Bae
    Toshifumi Gushima
    Noriyuki Saito
    Ikumi Yamanaka
    Yayoi Matsuo
    Shuro Yoshida
    Ichiro Kawano
    Hideho Henzan
    Shinji Shimoda
    Tetsuya Eto
    Kazuhiro Takahashi
    Bone Marrow Transplantation, 2019, 54 : 629 - 631
  • [2] Cmv Reactivation After Allogenic Hematopoietic Stem Cell Transplantation - Single Center Experience
    Balint, Milena Todorovic
    Pantic, Nikola
    Jankovic, Marko
    Djunic, Irena
    Smiljanic, Mihailo
    Gunjak, Tara
    Jovanovic, Tanja
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 272 - 273
  • [3] CYTOMEGALOVIRUS REACTIVATION RATES AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION: SINGLE CENTER EXPERIENCE
    Ozgur, G.
    Ozaydin, S.
    Yildirim, M.
    Ozturk, M.
    Cetin, T.
    LEUKEMIA RESEARCH, 2014, 38 : S60 - S61
  • [4] Outcomes In Allogeneic Hematopoietic Stem Cell Transplantation for Peripheral T-Cell Lymphoma: A Single Center's 12-Year Experience
    Lee, Hans C.
    Stockerl-Goldstein, Keith E.
    Zhang, Qin
    Cashen, Amanda
    BLOOD, 2010, 116 (21) : 976 - 976
  • [5] Prevention of cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation with valganciclovir: Single center experience
    Rzepecki, P.
    Barzal, J.
    Sarosiek, T.
    Oborska, S.
    Szczylik, C.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (01) : 140 - 142
  • [6] Outcomes of both high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation and conventional chemotherapy alone for mantle cell lymphoma: A 12-year single-center experience
    Cho, S-G
    Jeon, Y-W
    Yoon, J-H
    Lee, S-E
    Kim, S-Y
    Eom
    Ki-Seong, K.
    Kim, Y-J
    Kim, H-J
    Lee, S.
    Min, C-K
    Lee, J-W
    Min, W-S
    BONE MARROW TRANSPLANTATION, 2017, 52 : S449 - S450
  • [7] Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia
    P Kebriaei
    R M Saliba
    C Ma
    C Ippoliti
    D R Couriel
    M de Lima
    S Giralt
    M H Qazilbash
    J L Gajewski
    C S Ha
    R E Champlin
    I F Khouri
    Bone Marrow Transplantation, 2006, 38 : 203 - 209
  • [8] Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia
    Kebriaei, P.
    Saliba, R. M.
    Ma, C.
    Ippoliti, C.
    Couriel, D. R.
    de Lima, M.
    Giralt, S.
    Qazilbash, M. H.
    Gajewski, J. L.
    Ha, C. S.
    Champlin, R. E.
    Khouri, I. F.
    BONE MARROW TRANSPLANTATION, 2006, 38 (03) : 203 - 209
  • [9] A single center experience of hematopoietic stem cell transplantation
    Filiz, S.
    Uygun, Kocacik D.
    Celmeli, F.
    Boz, Bingol A.
    Yegin, O.
    Uygun, V
    Tezcan, Karasu G.
    Kupesiz, A.
    Hazar, V
    Yeilipek, A.
    ALLERGY, 2011, 66 : 659 - 659
  • [10] Nephrotic syndrome after hematopoietic stem cell transplantation: a single center experience
    Katz, O. Beyar
    Davila, E. Kruzel
    Zuckerman, T.
    Fineman, R.
    Haddad, N.
    Okasha, D.
    Henig, I.
    Rowe, J. M.
    Ofran, Y.
    MINERVA MEDICA, 2015, 106 (06) : 355 - 357